MarketCap
Facebook
X
TelegramAnnual report 2022
added 03-30-2023
Apollo Endosurgery Cash and Cash Equivalents 2011-2025 | APEN
Annual Cash and Cash Equivalents Apollo Endosurgery
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 57 M | 90.7 M | 36.2 M | 29.9 M | 24 M | 30.5 M | 19.1 M | 8.89 M | 17.3 M | 11.9 M | 24.6 M | 14.4 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 90.7 M | 8.89 M | 30.4 M |
Quarterly Cash and Cash Equivalents Apollo Endosurgery
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 66.9 M | - | 81.7 M | 90.7 M | 28.5 M | 30.5 M | 31.7 M | 36.2 M | 36.2 M | 36.2 M | 36.2 M | 29.9 M | 29.9 M | 29.9 M | 29.9 M | 24 M | 24 M | 24 M | 24 M | 30.5 M | 30.5 M | 30.5 M | 30.5 M | 19.1 M | 19.1 M | 19.1 M | 19.1 M | 21.7 M | 8.89 M | 8.89 M | 8.89 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M | 11.9 M | 11.9 M | 11.9 M | 11.9 M | 24.6 M | 24.6 M | 24.6 M | 24.6 M | 14.4 M | 14.4 M | 14.4 M | 14.4 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 90.7 M | 8.89 M | 26.3 M |
Cash and Cash Equivalents of other stocks in the Medical devices industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
233 M | - | - | $ 17.2 B |  USA |
 |
Acutus Medical
AFIB
|
19.2 M | - | -26.83 % | $ 2.62 M | USA |
 |
Apyx Medical Corporation
APYX
|
43.7 M | $ 3.83 | -0.91 % | $ 133 M | USA |
 |
Bio-Rad Laboratories
BIO
|
488 M | $ 306.74 | -0.45 % | $ 8.65 B | USA |
 |
BioSig Technologies
BSGM
|
142 K | - | 37.08 % | $ 85.7 M | USA |
 |
InMode Ltd.
INMD
|
68.9 M | $ 14.35 | -1.1 % | $ 1.14 B |  Israel |
 |
IRIDEX Corporation
IRIX
|
7.03 M | $ 0.99 | 7.52 % | $ 16 M | USA |
 |
Bruker Corporation
BRKR
|
183 M | $ 45.67 | 1.2 % | $ 6.8 K | USA |
 |
Allied Healthcare Products
AHPI
|
3.32 M | - | 3.58 % | $ 2.21 M | USA |
 |
Abbott Laboratories
ABT
|
7.62 B | $ 128.62 | 2.52 % | $ 224 B | USA |
 |
Boston Scientific Corporation
BSX
|
414 M | $ 91.86 | -0.78 % | $ 135 B | USA |
 |
Conformis
CFMS
|
48.7 M | - | - | $ 16.4 M | USA |
 |
LivaNova PLC
LIVN
|
429 M | $ 63.33 | 0.92 % | $ 3.44 B |  Britain |
 |
EDAP TMS S.A.
EDAP
|
24.7 M | $ 3.19 | 10.76 % | $ 119 M |  France |
 |
LENSAR
LNSR
|
16.3 M | $ 11.5 | -0.09 % | $ 132 M | USA |
 |
Cardiovascular Systems
CSII
|
66.4 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
144 M | - | -10.19 % | $ 1.99 M | USA |
 |
Neovasc
NVCN
|
51.5 M | - | - | $ 111 M |  Canada |
 |
Eargo
EAR
|
101 M | - | - | $ 10.2 M | USA |
 |
PAVmed
PAVM
|
19.6 M | $ 0.31 | -4.88 % | $ 2.24 M | USA |
 |
Dynatronics Corporation
DYNT
|
326 K | - | 14.99 % | $ 929 K | USA |
|
Cognyte Software Ltd.
CGNT
|
78.6 M | $ 9.6 | -2.64 % | $ 689 M | Israel |
 |
Profound Medical Corp.
PROF
|
26.2 M | $ 7.74 | 5.53 % | $ 180 M | Canada |
 |
Quanterix Corporation
QTRX
|
174 M | $ 7.5 | -0.86 % | $ 282 M | USA |
 |
IRadimed Corporation
IRMD
|
52.2 M | $ 97.18 | 0.99 % | $ 1.23 B | USA |
 |
Second Sight Medical Products
EYES
|
18.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
1.04 B | $ 163.64 | -1.08 % | $ 12.3 B | USA |
 |
Accuray Incorporated
ARAY
|
57.4 M | $ 1.05 | -0.94 % | $ 108 M | USA |
 |
Avinger
AVGR
|
5.28 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
20.1 M | $ 12.52 | -1.49 % | $ 338 M | USA |
 |
FONAR Corporation
FONR
|
46.8 M | $ 14.9 | 1.02 % | $ 97.7 M | USA |
 |
AxoGen
AXGN
|
27.6 M | $ 29.72 | -2.2 % | $ 1.32 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
239 M | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
1.02 M | - | -0.57 % | $ 7.12 M | USA |
 |
CONMED Corporation
CNMD
|
24.5 M | $ 40.32 | -1.26 % | $ 1.24 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
43.8 M | $ 17.74 | 0.8 % | $ 409 M | USA |
 |
Globus Medical
GMED
|
784 M | $ 86.69 | - | $ 11.8 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
246 M | $ 13.55 | 0.97 % | $ 1.04 B | USA |
 |
Aziyo Biologics
AZYO
|
19.3 M | - | 1.37 % | $ 20.5 M | USA |